These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 35111651)

  • 1. A narrative review of MRI acquisition for MR-guided-radiotherapy in prostate cancer.
    Yuan J; Poon DMC; Lo G; Wong OL; Cheung KY; Yu SK
    Quant Imaging Med Surg; 2022 Feb; 12(2):1585-1607. PubMed ID: 35111651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective Image Quality and Lesion Assessment in the Setting of MR-Guided Radiation Therapy of Prostate Cancer on an MR-Linac at 1.5 T: A Comparison to a Standard 3 T MRI.
    Almansour H; Afat S; Fritz V; Schick F; Nachbar M; Thorwarth D; Zips D; Müller AC; Nikolaou K; Othman AE; Wegener D
    Cancers (Basel); 2021 Mar; 13(7):. PubMed ID: 33810410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First 500 Fractions Delivered with a Magnetic Resonance-guided Radiotherapy System: Initial Experience.
    Sahin B; Zoto Mustafayev T; Gungor G; Aydin G; Yapici B; Atalar B; Ozyar E
    Cureus; 2019 Dec; 11(12):e6457. PubMed ID: 32025388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stereotactic Magnetic Resonance-Guided Adaptive and Non-Adaptive Radiotherapy on Combination MR-Linear Accelerators: Current Practice and Future Directions.
    Bryant JM; Weygand J; Keit E; Cruz-Chamorro R; Sandoval ML; Oraiqat IM; Andreozzi J; Redler G; Latifi K; Feygelman V; Rosenberg SA
    Cancers (Basel); 2023 Mar; 15(7):. PubMed ID: 37046741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reliability of MRI radiomics features in MR-guided radiotherapy for prostate cancer: Repeatability, reproducibility, and within-subject agreement.
    Xue C; Yuan J; Poon DM; Zhou Y; Yang B; Yu SK; Cheung YK
    Med Phys; 2021 Nov; 48(11):6976-6986. PubMed ID: 34562286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interrater agreement of contouring of the neurovascular bundles and internal pudendal arteries in neurovascular-sparing magnetic resonance-guided radiotherapy for localized prostate cancer.
    Teunissen FR; Wortel RC; Wessels FJ; Claes A; van de Pol SMG; Rasing MJA; Meijer RP; van Melick HHE; de Boer JCJ; Verkooijen HM; van der Voort van Zyp JRN
    Clin Transl Radiat Oncol; 2022 Jan; 32():29-34. PubMed ID: 34825071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison between target magnetic resonance imaging (MRI) in-gantry and cognitively directed transperineal or transrectal-guided prostate biopsies for Prostate Imaging-Reporting and Data System (PI-RADS) 3-5 MRI lesions.
    Yaxley AJ; Yaxley JW; Thangasamy IA; Ballard E; Pokorny MR
    BJU Int; 2017 Nov; 120 Suppl 3():43-50. PubMed ID: 28749035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Applications of Magnetic Resonance-Guided Radiotherapy: A Narrative Review.
    Ladbury C; Amini A; Schwer A; Liu A; Williams T; Lee P
    Cancers (Basel); 2023 May; 15(11):. PubMed ID: 37296879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of Central Nervous System Tumors on Combination MR-Linear Accelerators: Review of Current Practice and Future Directions.
    Bryant JM; Doniparthi A; Weygand J; Cruz-Chamorro R; Oraiqat IM; Andreozzi J; Graham J; Redler G; Latifi K; Feygelman V; Rosenberg SA; Yu HM; Oliver DE
    Cancers (Basel); 2023 Oct; 15(21):. PubMed ID: 37958374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Preliminary applicability evaluation of Prostate Imaging Reporting and Data System version 2 diagnostic score in 3.0T multi-parameters magnetic resonance imaging combined with prostate specific antigen density for prostate cancer].
    Zuo MZ; Zhao WL; Wei CG; Zhang CY; Wen R; Gu YF; Li MJ; Zhang YY; Wu JF; Li X; Shen JK
    Zhonghua Yi Xue Za Zhi; 2017 Dec; 97(47):3693-3698. PubMed ID: 29325321
    [No Abstract]   [Full Text] [Related]  

  • 11. Artificial Intelligence in magnetic Resonance guided Radiotherapy: Medical and physical considerations on state of art and future perspectives.
    Cusumano D; Boldrini L; Dhont J; Fiorino C; Green O; Güngör G; Jornet N; Klüter S; Landry G; Mattiucci GC; Placidi L; Reynaert N; Ruggieri R; Tanadini-Lang S; Thorwarth D; Yadav P; Yang Y; Valentini V; Verellen D; Indovina L
    Phys Med; 2021 May; 85():175-191. PubMed ID: 34022660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Online adaptive planning for prostate stereotactic body radiotherapy using a 1.5 Tesla magnetic resonance imaging-guided linear accelerator.
    Yang J; Vedam S; Lee B; Castillo P; Sobremonte A; Hughes N; Mohammedsaid M; Wang J; Choi S
    Phys Imaging Radiat Oncol; 2021 Jan; 17():20-24. PubMed ID: 33898773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Towards Accurate and Precise Image-Guided Radiotherapy: Clinical Applications of the MR-Linac.
    Randall JW; Rammohan N; Das IJ; Yadav P
    J Clin Med; 2022 Jul; 11(14):. PubMed ID: 35887808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. First experience of autonomous, un-supervised treatment planning integrated in adaptive MR-guided radiotherapy and delivered to a patient with prostate cancer.
    Künzel LA; Nachbar M; Hagmüller M; Gani C; Boeke S; Zips D; Thorwarth D
    Radiother Oncol; 2021 Jun; 159():197-201. PubMed ID: 33812912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of T2-Weighted MRI for Visualization and Sparing of Urethra with MR-Guided Radiation Therapy (MRgRT) On-Board MRI.
    Pham J; Savjani RR; Gao Y; Cao M; Hu P; Sheng K; Low DA; Steinberg M; Kishan AU; Yang Y
    Cancers (Basel); 2021 Jul; 13(14):. PubMed ID: 34298777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective study of diagnostic accuracy comparing prostate cancer detection by transrectal ultrasound-guided biopsy versus magnetic resonance (MR) imaging with subsequent MR-guided biopsy in men without previous prostate biopsies.
    Pokorny MR; de Rooij M; Duncan E; Schröder FH; Parkinson R; Barentsz JO; Thompson LC
    Eur Urol; 2014 Jul; 66(1):22-9. PubMed ID: 24666839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adaptive magnetic resonance-guided neurovascular-sparing radiotherapy for preservation of erectile function in prostate cancer patients.
    Teunissen FR; Wortel RC; Hes J; Willigenburg T; de Groot-van Breugel EN; de Boer JCJ; van Melick HHE; Verkooijen HM; van der Voort van Zyp JRN
    Phys Imaging Radiat Oncol; 2021 Oct; 20():5-10. PubMed ID: 34604553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MR-sequences for prostate cancer diagnostics: validation based on the PI-RADS scoring system and targeted MR-guided in-bore biopsy.
    Schimmöller L; Quentin M; Arsov C; Hiester A; Buchbender C; Rabenalt R; Albers P; Antoch G; Blondin D
    Eur Radiol; 2014 Oct; 24(10):2582-9. PubMed ID: 24972954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The MOMENTUM Study: An International Registry for the Evidence-Based Introduction of MR-Guided Adaptive Therapy.
    de Mol van Otterloo SR; Christodouleas JP; Blezer ELA; Akhiat H; Brown K; Choudhury A; Eggert D; Erickson BA; Faivre-Finn C; Fuller CD; Goldwein J; Hafeez S; Hall E; Harrington KJ; van der Heide UA; Huddart RA; Intven MPW; Kirby AM; Lalondrelle S; McCann C; Minsky BD; Mook S; Nowee ME; Oelfke U; Orrling K; Sahgal A; Sarmiento JG; Schultz CJ; Tersteeg RJHA; Tijssen RHN; Tree AC; van Triest B; Hall WA; Verkooijen HM
    Front Oncol; 2020; 10():1328. PubMed ID: 33014774
    [No Abstract]   [Full Text] [Related]  

  • 20. Prediction of High-grade Prostate Cancer Following Multiparametric Magnetic Resonance Imaging: Improving the Rotterdam European Randomized Study of Screening for Prostate Cancer Risk Calculators.
    Alberts AR; Roobol MJ; Verbeek JFM; Schoots IG; Chiu PK; Osses DF; Tijsterman JD; Beerlage HP; Mannaerts CK; Schimmöller L; Albers P; Arsov C
    Eur Urol; 2019 Feb; 75(2):310-318. PubMed ID: 30082150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.